Abstract:<p>Hyperglycemia can drive advanced glycation end product(AGE) accumulation and associated nucleus pulposus cell(NPC) dysfunction, but the basis for this activity has not been elucidated. Hypoxia‐inducible factor‐1α (HIF‐1α) is subject to cell‐type‐specific AGE‐mediated regulation. In the current study, we assessed the mechanistic relationship between AGE accumulation and HIF‐1α degradation in NPCs. Immunohistochemical staining of degenerated nucleus pulposus(NP) samples was used to assess AGE levels. AGE impact on NPC survival and glycolysis‐related gene expression was assessed via MTT assay and qRT‐PCR, while HIF‐1α expression in NPCs following AGE treatment was monitored via western blotting and qRT‐PCR. Additionally, a luciferase reporter assay was used to monitor HIF‐1α transcriptional activity. The importance of receptor for activated C‐kinase 1(RACK1) as a mediator of HIF‐1α degradation was evaluated through gain‐ and loss‐of‐function experiments. Competitive binding of RACK1 and HSP90 to HIF‐1α was evaluated via immunoprecipitation. Increased AGE accumulation was evident in NP samples from diabetic patients, and AGE treatment resulted in reduced HIF‐1α protein levels in NPCs that coincided with reduced HIF‐1α transcriptional activity. AGE treatment impaired the stability of HIF‐1α, leading to its RACK1‐mediated proteasomal degradation in a manner independent of the canonical PHD‐mediated degradation pathway. Additionally, RACK1 competed with HSP90 for HIF‐1α binding following AGE treatment. AGE treatment of NPCs leads to HIF‐1α protein degradation. RACK1 competes with HSP90 for HIF‐1α binding following AGE treatment, resulting in post‐translational HIF‐1α degradation. These results suggest that AGE is an intervertebral disc degeneration risk factor, and highlight potential avenues for the treatment or prevention of this disease.</p><p>This article is protected by copyright. All rights reserved.</p>

Advanced glycation end products promote intervertebral disc degeneration by transactivation of matrix metallopeptidase genes

Advanced Glycation End Products Upregulates The Expression Of Connexin43 Via Erk Mapk And Pi3k/Akt Pathways In Human Endothelial Cells

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

Role of Advanced Glycation End Products in Intervertebral Disc Degeneration: Mechanism and Therapeutic Potential

Obesity Mediates Apoptosis and Extracellular Matrix Metabolic Imbalances Via MAPK Pathway Activation in Intervertebral Disk Degeneration

Glucose-stimulated PGC-1α couples with CBP and Runx2 to mediate intervertebral disc degeneration through transactivation of ADAMTS4/5 in diet-induced obesity mice

Protein-bound AGEs Derived from Methylglyoxal Induce Pro-Inflammatory Response and Barrier Integrity Damage in Epithelial Cells by Disrupting the Retinol Metabolism

RACK1 mediates the advanced glycation end product‐induced degradation of HIF‐1α in nucleus pulposus cells via competing with HSP90 for HIF‐1α binding

From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration

Advanced glycation end products induce nucleus pulposus cell apoptosis by upregulating TXNIP via inhibiting glycolysis pathway in intervertebral disc degeneration

The Role of Mir-31-5p in the Development of Intervertebral Disc Degeneration and Its Therapeutic Potential.

Advanced glycation end products activate Smad signaling via TGF- -dependent and -independent mechanisms: implications for diabetic renal and vascular disease

Inhibition of Highland Barley Bran-Derived Carbon Dots on the Formation of Advanced Glycation End Products

High glucose mediates the ChREBP/p300 transcriptional complex to activate proapoptotic genes Puma and BAX and contributes to intervertebral disc degeneration

Inhibition of aberrant Hif1α activation delays intervertebral disc degeneration in adult mice

Genotoxic stress accelerates age-associated degenerative changes in intervertebral discs

Advanced Glycation End Products Inhibit Production and Activity of Matrix Metalloproteinase-2 in Human Umbilical Vein Endothelial Cells

HSP90 Inhibitor 17-AAG Attenuates Nucleus Pulposus Inflammation and Catabolism Induced by M1-Polarized Macrophages

Ginsenoside Rg3 exhibits anti-catabolic and anti-apoptotic effects in IL-1β treated human disc nucleus pulposus cells and in a rat model of disc degeneration by inactivating the MAPK pathway

Advanced glycation end products activated endothelial-to-mesenchymal transition in pancreatic islet endothelial cells and triggered islet fibrosis in diabetic mice

Glycyrrhizin suppresses inflammation and cell apoptosis by inhibition of HMGB1 via p38/p-JUK signaling pathway in attenuating intervertebral disc degeneration